AU2019203394B2 — Multi-unit drug delivery devices and methods
Assigned to Taris Biomedical LLC · Expires 2021-09-09 · 5y expired
What this patent protects
Implantable drug delivery devices include a housing defining a reservoir, a first unit within the reservoir, and a second unit within the reservoir. The first unit contains a drug and the second unit contains a functional agent that facilitates release of the drug. Intravesical…
USPTO Abstract
Implantable drug delivery devices include a housing defining a reservoir, a first unit within the reservoir, and a second unit within the reservoir. The first unit contains a drug and the second unit contains a functional agent that facilitates release of the drug. Intravesical drug delivery devices include a housing portion containing a drug formulation and a housing portion containing an excipient, and are configured to release the drug according to a first release profile and the excipient according to a second release profile. Methods include inserting any of these devices into a patient and releasing drug from the device. WO 2015/026813 PCT/US2014/051672 1/13 A-100 104 102 102 102 102 102 102 102 104 L 106 102 102 102 102 102 102 102 102 PRIOR ART FIG. I -200 210 210 210 210 202 202 202 tIJW 2404 A ::r206 208 210 210 210 210 210 202 202 202 FIG. 2 306 g- 300 310 310 302 302 302 310 310 308 310 310 310 302 302 310 310 310 FIG. 3 r- 400 410 410 410 410 S¶/4 410 410410410 410 402 FIG. 4
Drugs covered by this patent
- Gemzar (Gemcitabine Hydrochloride) · Accord Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.